ライフサイエンスコーパス: Epstein-Barr virus

1 lla zoster virus, human cytomegalovirus, and Epstein-Barr virus.

2 sine patch, which is absent in EBNA-1 of the Epstein-Barr virus.

3 such as varicella zoster virus and possibly Epstein-Barr virus.

4 tation of epitopes from different strains of Epstein-Barr virus.

5 LTL attrition, with no association found for Epstein-Barr virus.

6 ovirus, adenovirus, human herpesvirus 6, and Epstein-Barr virus.

7 virus, norovirus, rotavirus, parvovirus, and Epstein-Barr virus.

8 %; human herpesvirus [HHV] 6, 18%; HHV8, 6%; Epstein-Barr virus, 3%; herpes simplex virus 1, 3%; vari

9 o prevent infection with and reactivation of Epstein-Barr virus and cytomegalovirus and their associa

10 a conserved domain of EBNA-3B and ICP4 from Epstein-Barr virus and herpes simplex virus 1, respectiv

11 -protein interactions (PPI) networks between Epstein-Barr virus and Homo sapiens.

12 mology to a conserved domain of EBNA-3B from Epstein-Barr virus and ICP4 from herpes simplex virus 1,

13 estricted (407)HPVGEADYFEY(417) epitope from Epstein-Barr virus and naturally occurring variants at p

14 These data demonstrate that Epstein-Barr virus and possible other double-stranded DN

15 t by immortalization of thymic B cells using Epstein-Barr virus and TLR9 activation.

16 simplex, varicella zoster, cytomegalovirus, Epstein-Barr virus and Toxoplasma gondii in patients wit

17 Viruses (human herpesvirus 6, Epstein-Barr virus, and cytomegalovirus) were suspected

18 ruses, such as human cytomegalovirus (HCMV), Epstein-Barr virus, and HSV-1.

19 peptide pool consisting of cytomegalovirus, Epstein-Barr virus, and influenza virus (CEF).

20 rkel cell carcinoma-associated polyomavirus, Epstein-Barr virus, and Kaposi's sarcoma-associated herp

21 rpes simplex virus 1 and 2, cytomegalovirus, Epstein-Barr virus, and varicella zoster virus.

22 Epstein-Barr virus, another herpesvirus, has two propert

23 A biomarker of Epstein-Barr virus (anti-EBNA IgG seropositivity), infec

24 atural killer (NK) cell lymphoma (NNL) is an Epstein-Barr virus-associated lymphoma of cytotoxic NK c

25 Lymphomatoid granulomatosis (LYG) is a rare Epstein-Barr virus-associated lymphoproliferative disord

26 Here we show that expression of the Epstein-Barr virus B-cell attachment receptor, CD21, in

27 uman herpesvirus 6B, HHV-6A, adenovirus, and Epstein-Barr virus between days 0 and 100 post-HCT.

28 , 1 CSF specimen was positive for EV-D68 and Epstein-Barr virus by real-time polymerase chain reactio

29 Many double-stranded DNA viruses, such as Epstein-Barr virus, can establish persistent infection,

30 l carcinoma cells results in almost complete Epstein-Barr virus clearance.

31 at least 1 positive viremia during follow-up.Epstein-Barr virus D+/R- patients (P = 0.046) as well as

32 In the 328 patients with data for Epstein-Barr virus DNA, a detectable viral DNA titre was

33 Epstein-Barr virus drives autonomous B cell proliferatio

34 , TSPyV, HPyV9, HPyV10) and 5 herpesviruses (Epstein Barr virus (EBV), cytomegalovirus (CMV), herpes

35 nancy (mean gestational age = 11.1 weeks) to Epstein Barr virus (EBV), herpes simplex virus types 1 a

36 pients and is most often associated with the Epstein Barr virus (EBV).

37 subgroup (HR = 1.80, 95% CI = 1.36-2.38) and Epstein-Barr virus (EBV) (+) > 5% subgroup (HR = 1.59, 9

38 of replication of cytomegalovirus (CMV) and Epstein-Barr virus (EBV) (the most frequently detected H

39 P1) expression as observed in tumor cells of Epstein-Barr virus (EBV) -associated HL, we analyzed 3-d

40 s (EBNAs) encoded by the lymphoma-associated Epstein-Barr virus (EBV) activate MYC and silence BCL2L1

41 Infection with Epstein-Barr virus (EBV) affects most humans worldwide a

42 uman herpes virus (HHV)-6, HHV-7, chlamydia, Epstein-Barr virus (EBV) and bacterial 16S ribosomal DNA

43 to CD8 T cells specific for control viruses, Epstein-Barr virus (EBV) and cytomegalovirus (CMV), and

44 The human tumor viruses Epstein-Barr virus (EBV) and Kaposi sarcoma-associated h

45 The human gammaherpesviruses Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated

46 The gammaherpesviruses Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated

47 Clinically available drugs active against Epstein-Barr virus (EBV) and other human herpesviruses a

48 Endemic Burkitt lymphoma is associated with Epstein-Barr virus (EBV) and Plasmodium falciparum coinf

49 Epstein-Barr virus (EBV) and rhesus lymphocryptovirus (r

50 Infusions of T cells targeting Epstein-Barr virus (EBV) antigens have shown encouraging

51 Most patients infected with Epstein-Barr virus (EBV) are asymptomatic, have nonspeci

52 Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) are the most common, and althou

53 In the oral epithelium, peripheral stores of Epstein-Barr virus (EBV) are transmitted from infiltrati

54 Using Epstein-Barr virus (EBV) as a source of oncogenes, we ha

55 ted that infants in Kenya were infected with Epstein-Barr virus (EBV) at <6 months of age, suggesting

56 between polyomavirus JC (JC virus [JCV]) and Epstein-Barr virus (EBV) at sequences of JCV found infec

57 the herpes simplex virus 1 (HSV-1) ICP8 and Epstein-Barr virus (EBV) BALF2 proteins.

58 Mature human B cells infected by Epstein-Barr virus (EBV) become activated, grow, and pro

59 We previously showed that the Epstein-Barr virus (EBV) BFRF1 protein recruits the ESCR

60 The Epstein-Barr virus (EBV) BNLF2a gene product provides im

61 Epstein-Barr virus (EBV) can efficiently establish stabl

62 Epstein-Barr virus (EBV) causes endemic Burkitt lymphoma

63 Epstein-Barr virus (EBV) causes human lymphoid malignanc

64 Epstein-Barr virus (EBV) causes infectious mononucleosis

65 Epstein-Barr Virus (EBV) conversion of B-lymphocytes to

66 ived T cells specific for cytomegalovirus or Epstein-Barr virus (EBV) could effectively restore virus

67 We show that both 5' and 3' derivatives from Epstein-Barr virus (EBV) encoded miR-BART-18 precursor m

68 Epstein-Barr virus (EBV) encodes >44 viral microRNAs (mi

69 Epstein-Barr virus (EBV) encodes BPLF1, a lytic cycle pr

70 Epstein-Barr virus (EBV) entry into epithelial cells is

71 As a herpesvirus, Epstein-Barr virus (EBV) establishes a latent infection

72 Epstein-Barr virus (EBV) establishes a stable latent inf

73 Epstein-Barr virus (EBV) establishes latent infections a

74 Epstein-Barr virus (EBV) establishes lifelong infection

75 MP1) gene founder sequences and the level of Epstein-Barr virus (EBV) genome variability over time an

76 e bond (DB) C278/C335 in domain II (D-II) of Epstein-Barr virus (EBV) gH has an epithelial cell-speci

77 The Epstein-Barr virus (EBV) gp350 glycoprotein interacts wi

78 Epstein-Barr virus (EBV) has evolved exquisite controls

79 al cells in infection and persistence of the Epstein-Barr virus (EBV) have long been difficult to res

80 om anal samples; 2.7% (95% CI: 0.7-4.7%) for Epstein-Barr virus (EBV) immunoglobulin M (IgM) positivi

81 Latent infection of B lymphocytes by Epstein-Barr virus (EBV) in vitro results in their immor

82 Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) induce effector memory T-cell e

83 cells targeting viral antigens derived from Epstein-Barr virus (EBV) induce sustained complete tumor

84 Latent membrane protein 1 (LMP1) of Epstein-Barr virus (EBV) induces constitutive signaling

85 Latent Epstein-Barr virus (EBV) infection and cellular hypermet

86 essive head and neck cancer characterized by Epstein-Barr virus (EBV) infection and dense lymphocyte

87 al carcinoma (NPC) is highly associated with Epstein-Barr virus (EBV) infection and exhibits remarkab

88 The combination of Epstein-Barr virus (EBV) infection and high malaria expo

89 Epstein-Barr virus (EBV) infection and lytic replication

90 Epstein-Barr virus (EBV) infection in humans is a major

91 Importance: Diseases resulting from Epstein-Barr virus (EBV) infection in humans range from

92 HSCT) provides a unique opportunity to track Epstein-Barr virus (EBV) infection in the context of the

93 Epstein-Barr virus (EBV) infection is associated with B

94 Latent Epstein-Barr virus (EBV) infection is causally linked to

95 Primary Epstein-Barr virus (EBV) infection is the most common ca

96 Epstein-Barr virus (EBV) infection of B cells leads to t

97 Epstein-Barr virus (EBV) infection transforms B cells in

98 nked immunodeficiency with magnesium defect, Epstein-Barr virus (EBV) infection, and neoplasia' (XMEN

99 rine gammaherpesvirus 68 (MHV68), a model of Epstein-Barr virus (EBV) infection, and then after laten

100 , the patient developed primary asymptomatic Epstein-Barr virus (EBV) infection, followed by EBV+ B-c

101 noma (NPC) is closely associated with latent Epstein-Barr virus (EBV) infection.

102 in the disorder in Mg(2+) homeostasis after Epstein-Barr virus (EBV) infection.

103 Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections are a significant ca

104 Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections following allogeneic

105 R) capable of diagnosing different stages of Epstein-Barr virus (EBV) infections in clinical serum sa

106 ch is the case for cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections of humans.

107 Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections remain a major cause

108 Epstein-Barr virus (EBV) infects and transforms human pr

109 Epstein-Barr virus (EBV) infects greater than 90% of hum

110 Epstein-Barr Virus (EBV) infects human B cells and drive

111 Epstein-Barr virus (EBV) infects most of the world's pop

112 erial artificial chromosome (BAC).IMPORTANCE Epstein-Barr virus (EBV) infects the majority of the wor

113 BILF1 encoded by human Epstein-Barr virus (EBV) is a 7-transmembrane (7TM) G-pr

114 Epstein-Barr virus (EBV) is a common human pathogen that

115 Epstein-Barr Virus (EBV) is a gammaherpesvirus that infe

116 Epstein-Barr virus (EBV) is a human herpes virus that in

117 Epstein-Barr virus (EBV) is a lymphotropic gamma-herpesv

118 Epstein-Barr virus (EBV) is a tumor virus that establish

119 Epstein-Barr virus (EBV) is a ubiquitous gammaherpesviru

120 Epstein-Barr virus (EBV) is a ubiquitous gammaherpesviru

121 Epstein-Barr virus (EBV) is a ubiquitous human gammaherp

122 Epstein-Barr virus (EBV) is a ubiquitous pathogen of hum

123 Epstein-Barr virus (EBV) is a ubiquitous virus that esta

124 Epstein-Barr virus (EBV) is a well-established B-cell-tr

125 replication of the human gamma herpes virus Epstein-Barr virus (EBV) is an essential prerequisite fo

126 Epstein-Barr virus (EBV) is an important human pathogen

127 Epstein-Barr virus (EBV) is an oncogenic herpesvirus tha

128 Epstein-Barr virus (EBV) is an oncovirus associated with

129 The latent infection of Epstein-Barr virus (EBV) is associated with 1% of human

130 Epstein-Barr virus (EBV) is associated with both B cell

131 Epstein-Barr virus (EBV) is associated with multiple hum

132 Epstein-Barr virus (EBV) is implicated as an aetiologica

133 Epstein-Barr Virus (EBV) is involved in a wide range of

134 Infection with Epstein-Barr virus (EBV) is nearly ubiquitous in the hum

135 novel mechanisms of host control.IMPORTANCE Epstein-Barr virus (EBV) is transmitted orally, replicat

136 Epstein-Barr virus (EBV) is typically acquired asymptoma

137 Epstein-Barr virus (EBV) is usually acquired silently ea

138 program and DNA methylation state.IMPORTANCE Epstein-Barr virus (EBV) latency and carcinogenesis invo

139 Epstein-Barr virus (EBV) latency and its associated carc

140 Epstein-Barr virus (EBV) latent antigen EBNA3C is implic

141 Epstein-Barr virus (EBV) latent gene products cause huma

142 Epstein-Barr virus (EBV) latent infection is responsible

143 In this study, we provide evidence that Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1

144 Epstein-Barr virus (EBV) latent membrane protein-1 (LMP1

145 Epstein-Barr virus (EBV) latently infects normal B cells

146 We have previously shown that the Epstein-Barr virus (EBV) likely encodes hundreds of vira

147 Epstein-Barr virus (EBV) maintains a lifelong latent inf

148 Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) is th

149 Epstein-Barr Virus (EBV) Nuclear Antigen 1 (EBNA1)-media

150 The impact of Epstein-Barr virus (EBV) on human health is substantial,

151 es reactivation of the oncogenic herpesvirus Epstein-Barr virus (EBV) out of latency into lytic repli

152 defects often can be overcome by adding the Epstein-Barr virus (EBV) partitioning element, FR (i.e.,

153 Epstein-Barr Virus (EBV) persists for the lifetime of th

154 Epstein-Barr virus (EBV) plays important roles in the or

155 m patient samples the degree of diversity in Epstein-Barr virus (EBV) populations and the extent to w

156 Lytic infection by the Epstein-Barr virus (EBV) poses numerous health risks, su

157 rogenically impaired immune surveillance and Epstein-Barr virus (EBV) primary infection/reactivation

158 Epstein-Barr virus (EBV) produces a highly abundant nonc

159 Epstein-Barr virus (EBV) reactivation can cause signific

160 Epstein-Barr virus (EBV) reactivation involves the order

161 Using various Epstein-Barr virus (EBV) recombinants, we provide defini

162 Recent studies reported that posttransplant Epstein-Barr virus (EBV) replication is frequent and ind

163 ect of subclinical cytomegalovirus (CMV) and Epstein-Barr virus (EBV) replication on CD4(+) and CD8(+

164 Epstein-Barr virus (EBV) represents a major global healt

165 The lymphotropic Epstein-Barr virus (EBV) seems to avoid recognition by i

166 Epstein-Barr virus (EBV) seronegative status pretranspla

167 We investigated the effect of Epstein-Barr virus (EBV) serostatus on the overall outco

168 Epstein-Barr virus (EBV) SM protein is an essential lyti

169 Tumor Epstein-Barr virus (EBV) status was determined for 498 p

170 sociations by histological subtype and tumor Epstein-Barr virus (EBV) status.

171 sequences from an enlarged set of about 200 Epstein-Barr virus (EBV) strains, including many primary

172 Epstein-Barr virus (EBV) super-enhancers (ESEs) are esse

173 The ability of Epstein-Barr virus (EBV) to spread and persist in human

174 ecause of studies on the contribution of the Epstein-Barr virus (EBV) to the aggressiveness of nasoph

175 Epstein-Barr virus (EBV) transforms B cells to continuou

176 Oncogenic Epstein-Barr virus (EBV) uses various approaches to esca

177 We determined that Epstein-Barr virus (EBV) was the only virus detected in

178 Antibody responses to Epstein-Barr virus (EBV) were significantly higher in ca

179 Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) were the most commonly detected

180 he oral cavity is a persistent reservoir for Epstein-Barr virus (EBV) with lifelong infection of resi

181 Epstein-Barr virus (EBV), a B lymphotropic herpesvirus e

182 Most humans are infected with Epstein-Barr virus (EBV), a cancer-causing virus.

183 that recognized five common viral pathogens: Epstein-Barr virus (EBV), adenovirus (AdV), cytomegalovi

184 Epstein-Barr virus (EBV), aetiologically linked to nasop

185 Epstein-Barr virus (EBV), an oncogenic human virus, is a

186 ons in humans such as cytomegalovirus (CMV), Epstein-Barr virus (EBV), and adenovirus, among others.

187 viral replication of cytomegalovirus (CMV), Epstein-Barr virus (EBV), and BK polyomavirus (BKV) at t

188 for the detection of cytomegalovirus (CMV), Epstein-Barr virus (EBV), and BK virus (BKV).

189 he viral reactivation rates of HHV-6, HHV-7, Epstein-Barr virus (EBV), and cytomegalovirus (CMV) in d

190 es, including human papillomaviruses (HPVs), Epstein-Barr virus (EBV), and hepatitis B and C viruses

191 ection of closely related DNA viruses: KSHV, Epstein-Barr virus (EBV), and herpes simplexvirus-2 (HSV

192 Cytomegalovirus (CMV), Epstein-Barr virus (EBV), and HHV-6 were shed at high ra

193 Most people in the world are infected by Epstein-Barr virus (EBV), and it causes several human di

194 ses, including human cytomegalovirus (HCMV), Epstein-Barr virus (EBV), and Kaposi's sarcoma-associate

195 HIV) subtypes (A, B, C, D, E, G, and panel), Epstein-Barr Virus (EBV), and Kaposi's Sarcoma-associate

196 iral response to HSV-1 and the related virus Epstein-Barr virus (EBV), as well as influenza A virus (

197 itative PCR assays of cytomegalovirus (CMV), Epstein-Barr virus (EBV), BK virus (BKV), adenovirus (AD

198 or herpes simplex virus (HSV) types 1 and 2, Epstein-Barr virus (EBV), cytomegalovirus (CMV), HHV-6A,

199 The 2 strains of Epstein-Barr virus (EBV), EBV type 1 (EBV-1) and EBV-2,

200 For Epstein-Barr virus (EBV), gH/gL and gH/gL/gp42 are both

201 analysis for toxoplasmosis, cytomegalovirus, Epstein-Barr virus (EBV), herpes simplex virus I and II,

202 viremia episodes with cytomegalovirus (CMV), Epstein-Barr virus (EBV), human herpesvirus 6 (HHV-6), h

203 In lymphomas the Epstein-Barr virus (EBV), Kaposi's sarcoma herpesvirus (

204 dings of previously identified infections by Epstein-Barr virus (EBV), Kaposi's sarcoma herpesvirus (

205 Epstein-Barr virus (EBV), known as an oncovirus, is the

206 In B cells infected by the cancer-associated Epstein-Barr virus (EBV), RUNX3 and RUNX1 transcription

207 antigens from ubiquitous pathogens, such as Epstein-Barr virus (EBV), that persist in their host and

208 Unlike the well-studied Epstein-Barr virus (EBV), where gH/gL and gH/gL/gp42 com

209 logic homology to the human gammaherpesvirus Epstein-Barr virus (EBV), which infects over 90% of huma

210 n follicular helper T cells (TFH cells), and Epstein-Barr virus (EBV), which persists in B cells.

211 Most humans become infected with Epstein-Barr virus (EBV), which then persists for life.

212 's sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV)--is vital to capsid assembly, y

213 Epstein-Barr virus (EBV)-associated diseases of epitheli

214 Furthermore, oncogenic viruses, including Epstein-Barr virus (EBV)-associated human cancers, were

215 ted B-cell immune dysregulation during acute Epstein-Barr virus (EBV)-associated infectious mononucle

216 Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV)-associated malignancy typically

217 Epstein-Barr virus (EBV)-associated posttransplant lymph

218 t peripheral blood (PB) T cells to eliminate Epstein-Barr virus (EBV)-driven human B-cell lymphoma in

219 triggered by the gly-ala repeat sequence of Epstein-Barr virus (EBV)-encoded EBNA1, results in PI3Kd

220 Latent membrane protein 1 (LMP1) is an Epstein-Barr virus (EBV)-encoded oncoprotein that is pac

221 Functions of Epstein-Barr virus (EBV)-encoded RNAs (EBERs) were teste

222 We used models of Epstein-Barr virus (EBV)-induced B-cell transformation t

223 s been found to regulate lytic activation of Epstein-Barr virus (EBV)-infected cells, we asked if STA

224 A major hurdle to killing Epstein-Barr virus (EBV)-infected tumor cells using onco

225 d in the context of our current knowledge of Epstein-Barr virus (EBV)-modified exosomes.

226 T isoforms was obtained and expressed in the Epstein-Barr virus (EBV)-negative AGS cells.

227 sed throughout infection, can be detected in Epstein-Barr virus (EBV)-positive tumors, and manipulate

228 edominantly manifesting as susceptibility to Epstein-Barr virus (EBV)-related diseases.

229 vely, detected in cytomegalovirus (CMV)- and Epstein-Barr virus (EBV)-responsive CD4+ T cells followi

230 nt of LUBAC, interacts with LMP1 and IRF7 in Epstein-Barr virus (EBV)-transformed cells and that LUBA

231 By examining Epstein-Barr virus (EBV)-transformed lymphoblastoid cell

232 pic gamma-herpesvirus closely related to the Epstein-Barr virus (EBV).

233 adenylated isoform structures in replicating Epstein-Barr virus (EBV).

234 by examining proteins that are expressed by Epstein-Barr virus (EBV).

235 ella intermedia, Prevotella nigrescense, and Epstein-Barr virus (EBV).

236 ceptible to one specific viral pathogen, the Epstein-Barr virus (EBV).

237 ndant nuclear noncoding RNA expressed by the Epstein-Barr virus (EBV).

238 g the complex life cycle and pathogenesis of Epstein-Barr virus (EBV).

239 osi's sarcoma-associated herpesvirus [KSHV], Epstein-Barr virus [EBV], and herpes simplex virus 1 [HS

240 titis B core [HBc], hepatitis C virus [HCV], Epstein-Barr virus [EBV], or cytomegalovirus [CMV]) in K

241 Our previous study reported that Epstein-Barr virus(EBV)-encoded latent membrane protein

242 The contributions of major Epstein-Barr virus-encoded factors, including proteins,

243 The Epstein-Barr virus-encoded miR-BART20-5p inhibits T-bet

244 rom both adenovirus-associated (VA) RNAs and Epstein-Barr virus-encoded small RNAs (EBERs) with respe

245 lyssavirus, herpes simplex viruses 1 and 2, Epstein-Barr virus, enterovirus, cytomegalovirus, and ch

246 ctors included a high prevalence of previous Epstein-Barr virus exposure and a relatively low immunol

247 ere, we review our understanding of the path Epstein-Barr virus follows to move from a latent infecti

248 eveloped a novel helper-dependent adenovirus/Epstein-Barr virus (HDAd/EBV) hybrid reprogramming vecto

249 in Xenopus tropicalis, human cell lines, and Epstein-Barr virus; however, the biological significance

250 Here we used iPSCs derived from Epstein-Barr virus-immortalized B-lymphocytes to verify

251 o plays important roles in the life cycle of Epstein-Barr virus in B cells.

252 positive test results for cytomegalovirus or Epstein-Barr virus, indicating possible cross-reactivity

253 Here, we show that Epstein-Barr virus-induced 3 (EBI3) is expressed by huma

254 ll migration, the G protein-coupled receptor Epstein-Barr virus-induced gene 2 (EBI2 or GPR183) direc

255 rphan G-protein-coupled receptors, including Epstein-Barr virus-induced gene 2 (EBI2).

256 Epstein-Barr virus-induced gene 3 (EBI3) is a subunit of

257 se that expressed the extrafollicular marker Epstein-Barr virus-induced protein 2 (EBI2), but signifi

258 report that in human airway epithelial cells Epstein-Barr virus induces TRIM29, a member of the TRIM

259 In Epstein-Barr virus-infected epithelial cancers, the alte

260 As a demonstration, Epstein-Barr virus-infected lymphoblastoid cell lines (E

261 g intensity of immunosuppression, control of Epstein-Barr virus infection among transplant recipients

262 yngeal mucosal space, associated with latent Epstein-Barr virus infection in most cases.

263 Although Epstein-Barr virus infection is a known risk factor, oth

264 cells from a Burkitt's lymphoma with latent Epstein-Barr virus infection showed dramatic proliferati

265 s, such as the incidence of acute rejection, Epstein-Barr virus infection, sepsis, biliary and vascul

266 ation is distinct from MHC associations with Epstein-Barr virus infection.

267 more rarely T cells, associated with clonal Epstein-Barr virus infection.

268 is based on false-positive tests for primary Epstein-Barr virus infection.

269 This study reveals that Epstein-Barr virus interferes with normal human cell lif

270 nt for diverse functions of EBNA1.IMPORTANCE Epstein-Barr virus is a human gammaherpesvirus that is c

271 r efficient viral DNA replication.IMPORTANCE Epstein-Barr virus is the causative agent of infectious

272 Epstein-Barr virus latent membrane protein 2A (LMP2A) in

273 ns can be modulated by viral proteins (e.g., Epstein-Barr virus LMPs) to favor spread of transformed

274 These were IgG seropositivity to Epstein-Barr virus nuclear antigen (EBNA) (random effect

275 ent of the requirement for expression of the Epstein-Barr Virus nuclear antigen (EBNA), making it par

276 In contrast to homologous proteins such as Epstein-Barr virus nuclear antigen 1 (EBNA-1) of the rel

277 n vIRF1, which is identical to that found in Epstein-Barr virus nuclear antigen 1 (EBNA1) that intera

278 on factor 2) bound cooperatively with EBNA1 (Epstein-Barr virus nuclear antigen 1) at OriP.

279 Epstein-Barr virus nuclear antigen 3C (EBNA3C) repressio

280 tected regarding the risk of herpes simplex, Epstein-Barr virus or BK polyomavirus infections.

281 utologous VSTs specific for cytomegalovirus, Epstein-Barr virus, or adenovirus and genetically modifi

282 Few studies have reported Epstein-Barr virus-positive (EBV(+)) large B-cell lympho

283 tional Cancer Institute describe a series of Epstein-Barr virus-positive (EBV+) diffuse large B-cell

284 Epstein-Barr virus reactivation is increased, but is man

285 Epstein-Barr virus reactivation was substantially more c

286 Lee et al. show that a noncoding RNA from Epstein-Barr virus recruits a host transcription factor

287 memory T cells from the related herpesvirus Epstein-Barr virus remained undetectable.

288 bodies (aIRR = 2.03); in recipients who were Epstein-Barr virus-seronegative at the time of transplan

289 1 (EBNA-1) of the related gamma-herpesvirus Epstein-Barr virus, specific DNA recognition by LANA is

290 ed, which also affected cytomegalovirus- and Epstein-Barr virus-specific T cells.

291 ibrary using phage display technology and by Epstein-Barr virus transformation of switched memory B c

292 T3) and mRNA levels of STAT3 gene targets in Epstein-Barr virus-transformed B (EBV) cells, human peri

293 HLA-A*02:01 and HLA-B*27:05 expressed on the Epstein-Barr virus-transformed B cell line Jesthom and M

294 eoplastic (human papillomavirus+ tumors 35%, Epstein-Barr virus+ tumors 4%), vascular/lymphatic (veno

295 HSV UL37 with the human cytomegalovirus and Epstein-Barr virus UL37 homologs revealed that Y480 was

296 natural killer clone in response to chronic Epstein-Barr virus viremia.

297 Epstein-Barr virus was associated with all of the HLs an

298 tion to human cytomegalovirus, BK virus, and Epstein-Barr virus, while the importance of defining the

299 virus type 1, human herpesvirus type 6, and Epstein-Barr virus) with change in leukocyte telomere le

300 Epstein-Barr Virus Zta is a key transcriptional regulato